Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.4096
-0.0329 (-7.44%)
At close: Aug 3, 2026, 4:00 PM EDT
0.4099
+0.0003 (0.07%)
After-hours: Aug 3, 2026, 7:03 PM EDT
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $9.63 million as of August 3, 2026. Its market cap has decreased by -18.98% in one year.
Market Cap
9.63M
Enterprise Value
9.79M
1-Year Change
-18.98%
Ranking
Category
Stock Price
$0.41
ChartMarket Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $9.63M, a decrease of -78.12%. That is a compound annual growth rate of -62.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 9.63M | 6.14% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| McKesson | 100.24B |
| Cencora | 60.57B |
| Cardinal Health | 53.87B |
| Henry Schein | 9.77B |
| Akso Health Group | 1.35B |
| Accendra Health | 236.64M |
| EDAP TMS | 229.39M |
| 111, Inc. | 33.87M |